The project will involve the expansion of the Enki platform capabilities to incorporate additional high value biological property prediction functionality to enable the development of truly novel kinase inhibitors.
This record is a historical disbursement from Canada's open grants database — it documents a past payment, not an active program accepting applications.
View disbursement record →